CAS 112898-15-4
:2'-3'-O-(4-benzoylbenzoyl)adénosine*5'-triphosphate
2′(3′)-O-(4-Benzoylbenzoyl)adenosine 5′-triphosphate triethylammonium salt
CAS :Formule :C30H39N6O15P3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :816.5831Ref: IN-DA00391Y
1gÀ demander1mg102,00€5mg187,00€10mg217,00€25mg572,00€50mgÀ demander100mgÀ demander500mgÀ demanderBzATP triethylammonium salt
CAS :BzATP triethylammonium saltDegré de pureté :≥95%Masse moléculaire :1018.96g/mol2''(3'')-O-(4-Benzoylbenzoyl)adenosine-5''-triphosphate triethylammonium salt
CAS :Formule :C24H24N5O15P3·C18H45N3Degré de pureté :(HPLC) ≥ 95.0%Couleur et forme :White to off-white powderMasse moléculaire :1018.96BzATP triethylammonium salt
CAS :BzATP triethylammonium salt is a P2X7 receptor agonist.Formule :C30H39N6O15P3Degré de pureté :95% - 99.57%Couleur et forme :SolidMasse moléculaire :816.59BzATP Ammonium Salt (Mixture of 2'-3' isomers)
CAS :Applications BzATP Ammonium Salt is a selective P2X purinergic agonist. It is more potent than ATP at homodimeric P2X7 receptors.
References Cole, D., Yount, R.: J. Biol. Chem., 265, 22537 (1990); Atarashi, K., et al.: Nature, 455, 808 (2008)Formule :C24H24N5O15P3xNH3Couleur et forme :Off White SolidMasse moléculaire :715.392'(3')-O-(4-Benzoyl)benzoyladenosine-5'-triphosphate triethylammonium salt
CAS :2'(3')-O-(4-Benzoyl)benzoyladenosine-5'-triphosphate triethylammonium salt is a nucleoside analog of Adenosine-5'-triphosphate (ATP), a key player in cellular energy transfer. 2'(3')-O-(4-Benzoyl)benzoyl has been added to this molecule as well as a triethylammonium salt which helps to increase the stability of the molecule in solutions. 2'(3')-O-(4-Benzoyl)benzoyladenosine-5'-triphosphate triethylammonium salt has potential use as a tool for understanding how cells use ATP and how changes to ATP affect cellular processes. Other possible uses are in the study of how ATP interacts with enzymes.
Formule :C24H24N5O15P3·C6H15NDegré de pureté :Min. 75 Area-%Couleur et forme :White PowderMasse moléculaire :816.58 g/mol





